GSK picks ex-Tesco chief Lewis to chair consumer healthcare arm -source
Dave Lewis, Tesco CEO, speaks at the the British Chamber of Commerce annual conference in London, Britain, March 28, 2019. REUTERS/Peter Nicholls Purchase Licensing Rights
Dec 19 (Reuters) - British drugmaker GlaxoSmithKline Plc (GSK.L) has picked Dave Lewis, former chief executive of Tesco Plc (TSCO.L), to chair its consumer healthcare unit, which is due to be spun off next year, a source familiar with the matter said on Sunday.
Confirmation of Lewis's appointment as non-executive chairman of the arm that owns brands including Sensodyne toothpaste could come as soon as Monday, the source told Reuters.
Lewis left Tesco in September after six years as CEO. read more
GSK owns 68% of the unit and Pfizer Inc (PFE.N) the remainder. In July, GSK said its current head, Brian McNamara, would take over as CEO once it was spun off. read more
GSK said in October it was on track to spin the unit off next year at a valuation of upwards of 40 billion pounds ($53 billion). read more
($1 = 0.7551 pounds)
Sign up here.
Reporting by Anirudh Saligrama and Shivani Tanna in Bengaluru; editing by John Stonestreet
Our Standards: The Thomson Reuters Trust Principles.
